Biopharmaceutical Development Service
Resolian has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 500 scientists across three global labs.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.
Resolian broadens horizons and expertise with its expansion into China
Resolian, formerly known as Alliance Pharma Inc. and Drug Development Solutions Ltd., excels at delivering specialized services in the analytical and bioanalytical space. Join CEO, Patrick Bennett, as he discusses the mission, vision, and values of the new name. Bennett provides a look into the strategy behind the company’s expansion into the Chinese market, describing the unique expertise housed within each of its four global laboratories, and how the company ensures synergy and harmonization between them.
This video was filmed at AAPS 2023 PharmSci 360.
Want the latest expert interviews, articles, webinars, virtual summits and more direct to your inbox? Become a SelectScience member for free today>>
Trusted bioanalytical experts to support your trials
Resolian specializes in providing comprehensive support for bioanalytical assay development, validation, and sample analysis, spanning the entire spectrum from early drug evaluation to clinical trials. The flexibility and agility of Resolian sets it apart, ensuring it can cater to specific demands. In this video, see how it is the right size and shape to adapt to the diverse needs of its clients and how it is committed to evolving and growing to better serve its partners in the world of pharmaceutical research.
This video was filmed at AAPS 2023 PharmSci 360.
Want the latest expert interviews, articles, webinars, virtual summits and more direct to your inbox? Become a SelectScience member for free today>>
Resolian meets the needs of preclinical and clinical programs at any scale
Resolian (formerly Alliance Pharma Inc and Drug Development Solutions Ltd) is a global contract research organization (CRO) supporting pharmaceutical and biotech companies with specialized bioanalytical and analytical sciences solutions. Over 500 experts across the US, UK, and Australia, deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum.
Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.
